Skip to main content
Figure 3 | BMC Cardiovascular Disorders

Figure 3

From: Retrospective review of superficial femoral artery stenting in diabetic patients: thiazolidinedione use may decrease reinterventions

Figure 3

Freedom from SFA Stent TLR among diabetics with TASC A or B Lesions by TZD use. Freedom from TLR was 88.5% % for diabetics with TASC A or B lesions taking TZDs at the time of SFA stenting vs. 59.5% for those not taking a TZDs at 2 years. This difference was statistically significant, P = 0.02, with a standard error < 10% at all points on the graph.

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us